Changes in coagulative and fibrinolytic activities in patients with intracranial hemorrhage

Acta Neurochirurgica, Supplementum

Volumn , Issue 96, 2006, Pages 69-73

  Ebihara, T ^a   Kinoshita, K ^a   Utagawa, A ^a   Sakurai, A ^a   Furukawa, M ^a   Kitahata, Y ^a   Tominaga, Y ^a   Chiba, N ^a   Moriya, T ^a   Nagao, K ^a   Tanjoh, K ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cardiopulmonary arrest; Coagulation; D dimer; fibrinogen degradation products; fibrinolysis; intracerebral hemorrhage; plasmin inhibitor complex; PTF1+2; return of spontaneous circulation; subarachnoid hemorrhage

Indexed keywords

ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HUMAN; MALE; MIDDLE AGED; SUBARACHNOID HEMORRHAGE;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; FEMALE; FIBRINOLYSIS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; SUBARACHNOID HEMORRHAGE;

EID: 85052609099     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-211-30714-1_17     Document Type: Article

References (20)

1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709
2. Bone RC (1992) Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 152:1381-1389
3. Esmon CT (2001) Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 29 [Suppl] 7:48-51; discussion 51-52
4. Esmon CT, Taylor FB Jr, Snow TR (1991) Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 66:160-165
5. Gruber A, Reinprecht A, Illievich UM, Fitzgerald R, Dietrich W, Czech T, Richling B (1999) Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med 27:505-514
6. Ikeda K, Asakura H, Futami K, Yamashita J (1997) Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. Neurosurgery 41:344-349; discussion 349-350
7. Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G (2000) Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke 31:26-32
8. Le Roux PD, Elliott JP, Downey L, Newell DW, Grady MS, Mayberg MR, Eskridge JM, Winn HR (1995) Improved outcome after rupture of anterior circulation aneurysms: a retrospective 10-year review of 224 good-grade patients. J Neurosurg 83:394-402
9. Le Roux PD, Elliott JP, Newell DW, Grady MS, Winn HR (1996) Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 85:39-49
10. Levi M, Ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341:586-592
11. Levi M, van der Poll T, ten Cate H, van Deventer SJ (1997) The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 27:3-9
12. Levi M, Choi G, Schoots I, Schultz M, van der Poll T (2004) Beyond sepsis: activated protein C and ischemia-reperfusion injury. Crit Care Med 32 [Suppl] 5:309-312
13. Marder VJ, Feinstein DI, Francis CW, Colman RW (1994) Consumptive thrombohemorrhagic disorders. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn. J. B. Lippincott, Philadelphia, pp 1023-1063
14. Muller-Berghaus G, ten Cate H, Levi MM (1998) Disseminated intravascular coagulation. In: Verstraete M, Fuster V, Topol EJ (eds) Cardiovascular Thrombosis: Thrombocardiology and Thromboneurology, 2nd edn. Lippincott-Raven, Philadelphia, pp 114-120, 781-801
15. Nina P, Schisano G, Chiappetta F, Luisa Papa M, Maddaloni E, Brunori A, Capasso F, Corpetti MG, Demurtas F (2001) A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with Hunt-Hess grade and outcome. Surg Neurol 55:197-203
16. Peltonen S, Juvela S, Kaste M, Lassila R (1997) Hemostasis and fibrinolysis activation after subarachnoid hemorrhage. J Neurosurg 87:207-214
17. Shapiro S (1996) Management of subarachnoid hemorrhage patients who presented with respiratory arrest resuscitated with bystander CPR. Stroke 27:1780-1782
18. van der Poll T, Buller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW (1990) Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622-1627
19. Vergouwen MD, Frijns CJ, Roos YB, Rinkel GJ, Baas F, Vermeulen M (2004) Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurismal subarachnoid hemorrhage. Stroke 35:1280-1283
20. Yoshimoto Y, Tanaka Y, Hoya K (2001) Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 32:1989-1993